Chemotherapy Modulates Endocrine Therapy-Related Resistance Mutations in Metastatic Breast Cancer (vol 12, pg 764, 2019)

被引：0
|
作者：
Zhou, Dabo [1 ,2 ,3 ,4 ]
Liu, Liping [1 ,2 ,3 ,4 ]
Liu, Jingyu [1 ,2 ,3 ,4 ]
Tang, Yu [1 ,2 ,3 ,4 ]
Xiao, Mengjia [1 ,2 ,3 ,4 ]
Wang, Yikai [5 ]
He, Qiongzhi [6 ]
Hu, Zhe-Yu [1 ,2 ,3 ,4 ]
Ouyang, Quchang [1 ,2 ,3 ,4 ]
机构：
[1] Cent South Univ, Hunan Canc Hosp, Changsha 410013, Peoples R China
[2] Cent South Univ, Affiliated Canc Hosp, Xiangya Med Sch, Changsha 410013, Peoples R China
[3] Canc Hosp, Dept Breast Canc Med Oncol, Changsha 410013, Hunan, Peoples R China
[4] Cent South Univ, Xiangya Med Sch, Affiliated Canc Hosp, Dept Breast Canc Med Oncol, Changsha 410013, Peoples R China
[5] Emory Univ, Rollins Sch Publ Hlth, Dept Biostat & Bioinformat, Atlanta, GA 30322 USA
[6] Geneplus Beijing Inst, Beijing 102206, Peoples R China
来源：
TRANSLATIONAL ONCOLOGY | 2021年 / 14卷 / 12期
关键词：
D O I：
10.1016/j.tranon.2021.101226
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [21] The BMP Inhibitor Coco Reactivates Breast Cancer Cells at Lung Metastatic Sites (vol 150, pg 764, 2012)
    Gao, Hua
    Chakraborty, Goutam
    Lee-Lim, Ai Ping
    Mo, Qianxing
    Decker, Markus
    Vonica, Alin
    Shen, Ronglai
    Brogi, Edi
    Brivanlou, Ali H.
    Giancotti, Filippo G.
    CELL, 2012, 151 (06) : 1386 - 1388
  • [22] The oncology nurse's role in educating patients on endocrine therapy for metastatic breast cancer - Focus on fulvestrant (vol 25, pg S12, 2002)
    Lynn, J
    CANCER NURSING, 2002, 25 (03) : 195 - 195
  • [23] Chemotherapy and targeted therapy for breast cancer patients with hepatitis C virus infection (vol 26, pg 154, 2019)
    Talima, Soha
    Kassem, Hebatallah
    Kassem, Neemat
    BREAST CANCER, 2019, 26 (02) : 164 - 164
  • [24] Clinical outcomes with first-line chemotherapy versus endocrine therapy for adjuvant endocrine therapy-resistant metastatic breast cancer
    Shao, Bin
    Yang, Yanlian
    Qu, Jinrong
    Li, Huiping
    Song, Guohong
    Di, Lijun
    Jiang, Hanfang
    Yan, Ying
    Wang, Huan
    Liu, Xiaoran
    Wang, Jing
    Kong, Weiyao
    TRANSLATIONAL CANCER RESEARCH, 2018, 7 (03) : 676 - 685
  • [25] Structural underpinnings of oestrogen receptor mutations in endocrine therapy resistance (vol 18, pg 377, 2018)
    Katzenellenbogen, John A.
    Mayne, Christopher G.
    Katzenellenbogen, Benita S.
    Greene, Geoffrey L.
    Chandarlapaty, Sarat
    NATURE REVIEWS CANCER, 2018, 18 (10) : 662 - 662
  • [26] The role of HER2 mutations in resistance to endocrine therapy in ER plus breast cancer
    Nayar, U.
    Cohen, O.
    Oh, C.
    Wagle, N.
    CANCER RESEARCH, 2017, 77
  • [27] Successful Chemotherapy for a Case of Therapy-Related ALL with MLL Gene Rearrangement Following Treatment of Breast Cancer
    Xie, Xiaomeng
    Zhang, Chunhua
    Liu, Minfeng
    Yao, Guangyu
    Tong, Lin
    Chen, Jun
    Huang, Chuanqiang
    Guo, Zhaoze
    Ye, Changsheng
    BREAST JOURNAL, 2013, 19 (04): : 451 - 452
  • [28] Combination Chemotherapy of Azacitidine and Cetuximab for Therapy-Related Acute Myeloid Leukemia following Oxaliplatin for Metastatic Colorectal Cancer
    Hashimoto, Akari
    Takada, Kohichi
    Horiguchi, Hiroto
    Sato, Tsutomu
    Iyama, Satoshi
    Murase, Kazuyuki
    Kamihara, Yusuke
    Ono, Kaoru
    Tatekoshi, Ayumi
    Hayashi, Tsuyoshi
    Miyanishi, Koji
    Sato, Yasushi
    Furuhata, Tomohisa
    Kobune, Masayoshi
    Takimoto, Rishu
    Hirata, Koichi
    Kato, Junji
    CASE REPORTS IN ONCOLOGY, 2014, 7 (02): : 316 - 322
  • [29] Therapy-Related Leukemia following Docetaxel Chemotherapy for Metastatic Hormone-Sensitive Prostate Cancer: A Case Report
    Zhu, Chen
    Su, Jian
    Jin, Zhenhua
    Yuan, Lin
    Wei, Yunfei
    Xu, Yan
    CASE REPORTS IN ONCOLOGY, 2025, 18 (01): : 61 - 67
  • [30] Her-2/neu as predictive marker for endocrine therapy and chemotherapy in patients with metastatic breast cancer
    Köstler, WJ
    Zielinski, CC
    BREAST CANCER RESEARCH AND TREATMENT, 2003, 81 : S73 - S84
12345